Ranxin Zhang

First line anlotinib plus liposomal doxorubicin for locally advanced or metastatic soft tissue sarcoma: A prospective, single-arm trial

Lu Xie, Jie Xu, Xin Sun, 2022, Asian Pacific Journal of Tropical Medicine.

Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients

Xiaofang Wang, W. Guo, T. Ren, 2020, Journal of Nanobiotechnology.

Exosomal PD-L1 Derived From Osteosarcoma is Associated With Pulmonary Metastasis for Patients With Osteosarcoma

Xiaofang Wang, Yi Huang, Xin Sun, 2020 .

How to confront the high prevalence of pulmonary micro nodules (PMNs) in osteosarcoma patients?

Lu Xie, Jie Xu, Xiaodong Tang, 2022, International Orthopaedics.

Targeted inhibition of SCFSKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma

D. Zheng, Hongling Zhao, E. Schwartz, 2023, bioRxiv.

SKP2 knockout in Rb1/p53 deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosis.

D. Zheng, Jichuan Wang, Swapnil Singh, 2023, Molecular cancer therapeutics.

SKP2 knockout in Rb1/p53 deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosis

D. Zheng, Hongling Zhao, B. Hoang, 2023, bioRxiv.

Novel candidate metastasis‐associated genes for synovial sarcoma

Xiaodong Tang, T. Ren, H. Liang, 2024, Journal of cellular and molecular medicine.